[go: up one dir, main page]

AU1055597A - 2'-{{4'-halo-{1,1'-biphenyl}-4-yl}methyl}-5'-methyl-spiro{cy clopentane-1,7'(8'h)-{3h}imidazo{2,1-b}purin}-4'(5'h)-ones - Google Patents

2'-{{4'-halo-{1,1'-biphenyl}-4-yl}methyl}-5'-methyl-spiro{cy clopentane-1,7'(8'h)-{3h}imidazo{2,1-b}purin}-4'(5'h)-ones

Info

Publication number
AU1055597A
AU1055597A AU10555/97A AU1055597A AU1055597A AU 1055597 A AU1055597 A AU 1055597A AU 10555/97 A AU10555/97 A AU 10555/97A AU 1055597 A AU1055597 A AU 1055597A AU 1055597 A AU1055597 A AU 1055597A
Authority
AU
Australia
Prior art keywords
methyl
clopentane
purin
imidazo
spiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10555/97A
Inventor
Brian A. Mckittrick
Deen Tulshian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU1055597A publication Critical patent/AU1055597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU10555/97A 1995-11-28 1996-11-26 2'-{{4'-halo-{1,1'-biphenyl}-4-yl}methyl}-5'-methyl-spiro{cy clopentane-1,7'(8'h)-{3h}imidazo{2,1-b}purin}-4'(5'h)-ones Abandoned AU1055597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56371795A 1995-11-28 1995-11-28
US563717 1995-11-28
PCT/US1996/018550 WO1997019947A1 (en) 1995-11-28 1996-11-26 2'-[[4'-HALO-[1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO[CYCLOPENTANE-1,7'(8'H)-[3H]IMIDAZO[2,1-b]PURIN]-4'(5'H)-ONES

Publications (1)

Publication Number Publication Date
AU1055597A true AU1055597A (en) 1997-06-19

Family

ID=24251614

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10555/97A Abandoned AU1055597A (en) 1995-11-28 1996-11-26 2'-{{4'-halo-{1,1'-biphenyl}-4-yl}methyl}-5'-methyl-spiro{cy clopentane-1,7'(8'h)-{3h}imidazo{2,1-b}purin}-4'(5'h)-ones

Country Status (8)

Country Link
EP (1) EP0863902A1 (en)
JP (1) JP2000501095A (en)
AR (1) AR004752A1 (en)
AU (1) AU1055597A (en)
CA (1) CA2237956A1 (en)
CO (1) CO4480029A1 (en)
WO (1) WO1997019947A1 (en)
ZA (1) ZA969888B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326379B1 (en) 1998-09-16 2001-12-04 Bristol-Myers Squibb Co. Fused pyridine inhibitors of cGMP phosphodiesterase
CN1434825A (en) 1999-12-24 2003-08-06 拜尔公司 Imidazo[1,3,5]triazinones and their applications
WO2001047934A1 (en) 1999-12-24 2001-07-05 Bayer Aktiengesellschaft Isoxazolo pyrimidinones and the use thereof
ES2231311T3 (en) 1999-12-24 2005-05-16 Bayer Healthcare Ag TRIAZOLOTRIAZINONAS AND ITS USE.
KR102590848B1 (en) 2016-12-28 2023-10-19 다트 뉴로사이언스, 엘엘씨 Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors
ES2902365T3 (en) 2017-11-27 2022-03-28 Dart Neuroscience Llc Substituted furanopyrimidine compounds as PDE1 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238609A (en) * 1990-06-21 1993-12-23 Schering Corp Polycyclic guanine derivatives; preparation, pharmaceutical compositions,
US5939419A (en) * 1993-02-26 1999-08-17 Schering-Plough Corporation 2-benzyl-polycyclic guanine derivatives and process for preparing them

Also Published As

Publication number Publication date
MX9804198A (en) 1998-10-31
EP0863902A1 (en) 1998-09-16
WO1997019947A1 (en) 1997-06-05
ZA969888B (en) 1997-05-26
CA2237956A1 (en) 1997-06-05
AR004752A1 (en) 1999-03-10
JP2000501095A (en) 2000-02-02
CO4480029A1 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
EP0768312A3 (en) Bis-Staurosporine and K-252a derivatives
AU5403694A (en) Bladder damper
AU7409196A (en) Process improvement in the synthesis of N-{3-(3-cyanopyrazolo{1,5-a}pyrimidin-7-yl)phenyl}-n-ethyl- acetamide
AU7334194A (en) Characteristic of body part determined
AU3349593A (en) Polymeric tanning agents
AU9307098A (en) Spiro{pyrrolidine-2,3'-oxindole} compounds and methods of use
AU6217196A (en) Improved cement admixture
AU1055597A (en) 2'-{{4'-halo-{1,1'-biphenyl}-4-yl}methyl}-5'-methyl-spiro{cy clopentane-1,7'(8'h)-{3h}imidazo{2,1-b}purin}-4'(5'h)-ones
EP0613050A3 (en) Universal negative tone photoresist.
AU8334591A (en) Therapeutically active mixture of glutathion and anthocyan compounds
SG50604A1 (en) Water proofing liner
AU5937994A (en) Oxa(thia)-diazol-oxy-phenylacrylates
AU5481796A (en) Improved processability of metallocene-catalyzed polyolefins
AU7867894A (en) Dog walking accessory
FR2626678B1 (en) RADAR, ESPECIALLY FOR CORRECTION OF ARTILLERY
HRP960199B1 (en) SYNTHESIS OF AN INTERMEDIATE FOR THE PREPARATION OF 5,6-DIHYDRO-(S)-4-(ETHYLAMINO)-(S)-6-METHYL-4H-THIENO(2,3-b)THIOPYRAN-2-SULFONAMIDE 7,7-DIOXIDE INTERMEDIATES AND RELATED COMPOUNDS
HUT64034A (en) Process for producing 3-(hydroxymethyl)-1-propalgylimidazolidine-2,4-dione and its intermediates
EP0592108A3 (en) Solid area toner reduction
AU566869B2 (en) Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
GB2269014B (en) Assay of NADH
AU6418396A (en) Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide
ZA964358B (en) "DNA encoding cellular homologue of the SV40 Large T antigen".
IE893025L (en) IMIDAZO (2,1-b) QUINAZOLIN-5 (3H) - ONES
AU6489896A (en) N-(acyloxymethyl or hydroxymethyl) (optionally (oxa or thia) substituted)bicyclo({2.2.1} or {2.2.2})azalk(an or en)one compounds
ZA939228B (en) Novel triazolopyrimidones their preparation and use